Literature DB >> 20074285

Expression of LIF and LIF receptor beta in Alzheimer's and Parkinson's diseases.

M Soilu-Hänninen1, E Broberg, M Röyttä, P Mattila, J Rinne, V Hukkanen.   

Abstract

BACKGROUND: Signaling through the leukemia inhibitory factor (LIF) receptor (LIFR) is crucial for nervous system development. There are few studies concerning the expression of LIF and LIFR in normal and degenerating adult human brain.
OBJECTIVES: To study the expression of LIF and LIFR in Alzheimer's disease (AD), Parkinson's disease (PD), and control brains. PATIENTS AND METHODS: LIF and LIFR mRNA copy numbers were determined by quantitative real-time RT-PCR from four brain regions of 34 patients with AD, 40 patients with PD, and 40 controls. Immunohistochemistry was performed in seven PD and in four AD patients and in seven normal controls.
RESULTS: In general, the LIF copy numbers were 1 log higher than the LIFR copy numbers. In the AD brains, LIF expression was higher than in the controls in the hippocampus and in the temporal cortex, and in the PD brains in the hippocampus and in the anterior cingulated cortex. Expressions of LIF and LIFR in different brain regions were opposite except for the AD hippocampus and PD anterior cingulated cortex, where the expression patterns were parallel.
CONCLUSIONS: Co-operative expression of LIF and LIFR in AD hippocampus and PD anterior cingulated cortex may indicate a role for LIF in neuronal damage or repair in these sites.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20074285     DOI: 10.1111/j.1600-0404.2009.01179.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  7 in total

1.  Neuroregenerative and protective functions of Leukemia Inhibitory Factor in perinatal hypoxic-ischemic brain injury.

Authors:  Jie Lin; Yusuke Niimi; Mariano Guardia Clausi; Hur Dolunay Kanal; Steven W Levison
Journal:  Exp Neurol       Date:  2020-04-19       Impact factor: 5.330

2.  Selenate enhances STAT3 transcriptional activity in endothelial cells: differential actions of selenate and selenite on LIF cytokine signaling and cell viability.

Authors:  Hani J Alturkmani; Carlos Zgheib; Fouad A Zouein; Nour Eddin F Alshaaer; Mazen Kurdi; George W Booz
Journal:  J Inorg Biochem       Date:  2012-01-28       Impact factor: 4.155

3.  Adenosine A2B receptor-mediated leukemia inhibitory factor release from astrocytes protects cortical neurons against excitotoxicity.

Authors:  Shamsudheen Moidunny; Jonathan Vinet; Evelyn Wesseling; Johan Bijzet; Chu-Hsin Shieh; Sven C D van Ijzendoorn; Paola Bezzi; Hendrikus W G M Boddeke; Knut Biber
Journal:  J Neuroinflammation       Date:  2012-08-16       Impact factor: 8.322

4.  LIF, a Novel Myokine, Protects Against Amyloid-Beta-Induced Neurotoxicity via Akt-Mediated Autophagy Signaling in Hippocampal Cells.

Authors:  Hye Jeong Lee; Jung Ok Lee; Yong Woo Lee; Shin Ae Kim; Il Hyeok Seo; Jeong Ah Han; Min Ju Kang; Su Jin Kim; Yun-Ho Cho; Joong-Jean Park; Jong-Il Choi; Sun Hwa Park; Hyeon Soo Kim
Journal:  Int J Neuropsychopharmacol       Date:  2019-06-03       Impact factor: 5.176

Review 5.  Physical Exercise-Induced Myokines in Neurodegenerative Diseases.

Authors:  Banseok Lee; Myeongcheol Shin; Youngjae Park; So-Yoon Won; Kyoung Sang Cho
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

6.  Loss of APP in mice increases thigmotaxis and is associated with elevated brain expression of IL-13 and IP-10/CXCL10.

Authors:  Karina Mayagoitia; Andrew J Tolan; Shohali Shammi; Samuel D Shin; Jesus A Menchaca; Johnny D Figueroa; Christopher G Wilson; Denise L Bellinger; Abu Shufian Ishtiaq Ahmed; Salvador Soriano
Journal:  Physiol Behav       Date:  2021-07-19

7.  A novel missense mutation in oncostatin M receptor beta causing primary localized cutaneous amyloidosis.

Authors:  Marjan Saeedi; Azadeh Ebrahim-Habibi; Alireza Haghighi; Fariba Zarrabi; Mahsa M Amoli; Reza M Robati
Journal:  Biomed Res Int       Date:  2014-06-26       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.